These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17698828)

  • 1. Canada's approach to conflict- of-interest oversight.
    Ogbogu U
    CMAJ; 2007 Aug; 177(4):375-6. PubMed ID: 17698828
    [No Abstract]   [Full Text] [Related]  

  • 2. Health Canada's new standards on conflict of interest.
    Yeates N
    CMAJ; 2007 Oct; 177(8):900; author reply 900. PubMed ID: 17923664
    [No Abstract]   [Full Text] [Related]  

  • 3. US proposes more stringent conflict-of-interest rules.
    Kondro W
    CMAJ; 2007 May; 176(11):1571-2. PubMed ID: 17515579
    [No Abstract]   [Full Text] [Related]  

  • 4. Conflicts cause FDA to review advisory committees.
    Kondro W
    CMAJ; 2006 Jul; 175(1):23. PubMed ID: 16818900
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA is criticised for hinting it may loosen conflict of interest rules.
    Lenzer J
    BMJ; 2011 Aug; 343():d5070. PubMed ID: 21824909
    [No Abstract]   [Full Text] [Related]  

  • 6. The conflict of interest charade.
    Somberg J
    Am J Ther; 2013; 20(6):591. PubMed ID: 24247032
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA revamps committee conflict-of-interest rules.
    Finkelstein JB
    J Natl Cancer Inst; 2006 Oct; 98(19):1354-5. PubMed ID: 17018777
    [No Abstract]   [Full Text] [Related]  

  • 8. US advisory panellists on drug's safety had ties to manufacturers.
    Lenzer J; Epstein K
    BMJ; 2012 Jan; 344():e244. PubMed ID: 22234908
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA needs a more "nuanced" approach to advisers' conflicts of interest, researchers say.
    Dyer O
    BMJ; 2014 Sep; 349():g5665. PubMed ID: 25227397
    [No Abstract]   [Full Text] [Related]  

  • 10. Financial conflicts of interest and the Food and Drug Administration's Advisory Committees.
    Steinbrook R
    N Engl J Med; 2005 Jul; 353(2):116-8. PubMed ID: 16014880
    [No Abstract]   [Full Text] [Related]  

  • 11. What's wrong with money in science.
    Stossel T; Shaywitz D
    Washington Post; 2006 Jul; ():B3. PubMed ID: 16838447
    [No Abstract]   [Full Text] [Related]  

  • 12. Group says FDA, advisory panels show bias toward drug approvals.
    Vedantam S
    Washington Post; 2006 Aug; ():A13. PubMed ID: 16941783
    [No Abstract]   [Full Text] [Related]  

  • 13. MPs call for removal of Health Canada's breast-implant panel members.
    Eggertson L
    CMAJ; 2005 Nov; 173(10):1144. PubMed ID: 16275959
    [No Abstract]   [Full Text] [Related]  

  • 14. When is a point of view a conflict of interest?
    Lenzer J
    BMJ; 2016 Nov; 355():i6194. PubMed ID: 27881367
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction between optometrists and industry representatives.
    Optometry; 2009 Mar; 80(3):149-53. PubMed ID: 19271358
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflict questions. Advisory board members say conflicts avoidable.
    Conn J
    Mod Healthc; 2006 Dec; 36(48):18. PubMed ID: 17183808
    [No Abstract]   [Full Text] [Related]  

  • 17. Conflicts of Interest Among Patient and Consumer Representatives to U.S. Food and Drug Administration Drug Advisory Committees.
    Graham SS; Card DJ; Ahn S; Kim SY; Kessler MM; Olson MK
    Ann Intern Med; 2016 Oct; 165(8):606-607. PubMed ID: 27750309
    [No Abstract]   [Full Text] [Related]  

  • 18. Oncologic Drugs Advisory Committee and conflicts of interest.
    Burki TK
    Lancet Oncol; 2016 Mar; 17(3):e95. PubMed ID: 26877161
    [No Abstract]   [Full Text] [Related]  

  • 19. Advisory committees at FDA: the Hinchey Amendment and "conflict of interest" waivers.
    Lietzan E
    J Health Law; 2006; 39(4):415-49. PubMed ID: 17402656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings.
    Lammers A; Edmiston J; Kaestner V; Prasad V
    Mayo Clin Proc; 2017 Jul; 92(7):1164-1166. PubMed ID: 28688469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.